Anne obtained her PhD in Tumor Biology at the University of Georgetown University in Washington DC, USA in 2009, and trained as a postdoctoral fellow at the National Institutes of Health in Bethesda, USA in anti-MEK resistance mechanisms in pancreatic cancer. Anne joined the Federal Agency for Medicinal and Health Products in Brussels, Belgium in 2014 as a non-clinical assessor. She is particularly involved in the assessment of oncological products, at different stages of drug development, including applications for clinical trials in early phase.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.